Results of the randomized trial show opioid prescribing decreases after a clinician learns of a patient’s fatal overdose.
The researchers find Medicaid eligibility expansions are linked to increases in prescription fills for diabetes drugs.
Matthew Fielder examines how premiums would change in 2019 absent recent policy changes that are set to take effect.
High-deductible health plans may have unintended consequences for patients.
Mark Hall examines the causes of instability in the individual market and identifies measures to help improve stability based off of interviews with key stakeholders in 10 states.
More than one million Part D enrollees who were not eligible for cost assistance reached the catastrophic coverage in 2015.
In this study, researchers found a cumulative advantage of higher levels of education for psychosocial functioning in older adults.
Drug innovation in the last decade increased productivity by 4.8 million work days, resulting in $221 billion in annual wages.
Older blacks and US-born and foreign-born Hispanics report more chronic stress exposure than whites and are two to three times as likely to experience financial strain and housing-related stress.
Darius Lakdawalla reviews the economics literature on the pharmaceutical industry, focusing particularly on its positive and normative implications for the innovation, pricing, and marketing decisions of pharmaceutical firms.